Silo Pharma/$SILO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Silo Pharma
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
Ticker
$SILO
Sector
Primary listing
Employees
3
Headquarters
Website
Silo Pharma Metrics
BasicAdvanced
$6.3m
-
-$6.80
0.75
-
Price and volume
Market cap
$6.3m
Beta
0.75
52-week high
$6.78
52-week low
$5.00
Financial strength
Current ratio
9.653
Quick ratio
8.558
Interest coverage (TTM)
-123.84%
Profitability
EBITDA (TTM)
-4.77
Gross margin (TTM)
11.90%
Net profit margin (TTM)
-6,717.40%
Operating margin (TTM)
-6,631.35%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-46.26%
Return on equity (TTM)
-99.94%
Valuation
Price to revenue (TTM)
57.419
Price to book
1.11
Price to tangible book (TTM)
1.15
Price to free cash flow (TTM)
-1.077
Free cash flow yield (TTM)
-92.84%
Free cash flow per share (TTM)
-5.394
Growth
Earnings per share change (TTM)
-59.96%
10-year revenue growth (CAGR)
2.38%
3-year earnings per share growth (CAGR)
-34.76%
10-year earnings per share growth (CAGR)
-1.66%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs